Boston Scientific Corp.

Medical device manufacturer Boston Scientific has finalized the $210-million acquisition of EndoChoice Holdings, Inc. in Georgia, the Marlborough company announced Tuesday.

Marlborough-based Boston Scientific is continuing its acquisition spree with the buyout of the gynecology and urology portfolio of Distal Access, LLC.

Marlborough medical device manufacturer Boston Scientific announced on Friday it has extended the timeline for its $210-million acquisition of EndoChoice Holdings, Inc. in Georgia.

Boston Scientific of Marlborough generated $2.1 billion in sales and $368 million in earnings in its third quarter, the company announced Wednesday.

Ian Meredith will join Boston Scientific as executive vice president and global chief medical officer beginning in January, the company announced Monday.

Marlborough medical device manufacturer Boston Scientific announced on Friday it was moving forward on a $210-million acquisition of EndoChoice Holdings, Inc. in Georgia.

Boston Scientific has entered into an agreement to acquire an endoscopic company for approximately $210 million.

The U.S. Food and Drug Administration (FDA) has approved an implanted defibrillator system from Boston Scientific for use with MRI machines.

Boston Scientific continues to press forward with more than $2 billion in sales in the second quarter of the year, growing adjusted earnings year-over-year despite $618 million in litigation costs.

Boston Scientific announced Wednesday its acquisition of chronic pain treatment firm Cosman Medical, as the Marlborough company keeps its eyes set on non-opioid treatments.